alpha-Thujene is a bicyclic monoterpene found across several aromatic oils, especially frankincense-type resins and some savory or herb materials. The strongest live evidence for this constituent is chemical identity, occurrence, and biosynthetic context rather than isolated human or clinical effects. For AromaForge, it is best framed as a composition marker with limited constituent-specific pharmacology and safety literature, so any benefit-style language should stay cautious and non-medical.
Chemical identity and composition
PubChem lists alpha-thujene as CID 17868 with formula C10H16 and IUPAC name 2-methyl-5-propan-2-ylbicyclo[3.1.0]hex-2-ene. In the local archive it is most associated with frankincense profiles: Boswellia frereana is recorded at 14.5-43.9%, Boswellia carterii at 7.9%, and summer savory at 1.93%, which makes it a useful marker for resinous and spicy-herbal chemotypes rather than a universally dominant terpene.
Aroma and practical use
- Use the recorded woody, green, herbal, terpenic, herbaceous descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A 2012 chromatographic differentiation study reported alpha-thujene among the leading quantified volatile markers in Boswellia carterii essential oil, with an average value of 7.9%.
A 2012 chromatographic differentiation study reported alpha-thujene among the leading quantified volatile markers in Boswellia carterii essential oil, with an average value of 7.9%.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
A 2022 authentication study of commercial and lab-distilled Boswellia carteri oils reported alpha-thujene ranging from 0.4% to 11.6% in commercial samples and much higher in some lab-distilled samples, reinforcing its value as an origin and processing marker.
A 2022 authentication study of commercial and lab-distilled Boswellia carteri oils reported alpha-thujene ranging from 0.4% to 11.6% in commercial samples and much higher in some lab-distilled samples, reinforcing its value as an origin and processing marker.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
A monoterpene cyclase paper found that purified gamma-terpinene synthase could also generate small amounts of alpha-thujene from geranyl pyrophosphate.
A monoterpene cyclase paper found that purified gamma-terpinene synthase could also generate small amounts of alpha-thujene from geranyl pyrophosphate.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
A study on Salvia species reported alpha-thujene-rich oil in Salvia pilifera and linked the whole oil, not isolated alpha-thujene, to antioxidant and antimicrobial testing outcomes.
A study on Salvia species reported alpha-thujene-rich oil in Salvia pilifera and linked the whole oil, not isolated alpha-thujene, to antioxidant and antimicrobial testing outcomes.
This experimental finding does not establish benefit, dose or safety in people using this blend.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
No numeric constituent-specific use limit is available here. Missing is not an unrestricted-use clearance.
Direct constituent-specific toxicology for alpha-thujene was sparse in the live search compared with better-studied monoterpenes such as alpha-pinene or thujone.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
A fragrance-material listing reviewed during the search showed no clear standalone use-level recommendation for routine fragrance or flavor deployment, so finished-product safety should be inferred from the whole oil and broader monoterpene handling practices rather than from a strong alpha-thujene monograph.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
These are research candidates recorded in the interaction matrix. They do not add a proven-amplification bonus to the score.
gamma-TerpineneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro mechanistic · antioxidant
No source citation attached.
Read gamma-Terpinene report →TerpinoleneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro mechanistic · antioxidant
No source citation attached.
Read Terpinolene report →Carvacrol methyl etherAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
review · whole_oil
No source citation attached.
Read Carvacrol methyl ether report →How the effects were investigated
monoterpene cyclase product
A terpene biosynthesis study reported alpha-thujene as a minor cyclization product from geranyl pyrophosphate, supporting its placement as a natural monoterpene-formation product rather than a uniquely targeted bioactive.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (6)
- The live search did not surface strong isolated human, clinical, or constituent-specific pharmacology literature for alpha-thujene.
- Most biological signals involving alpha-thujene were mixture-level essential-oil results, so attribution to the single molecule remains weak.
- Standalone safety, dermal, and inhalation guidance for alpha-thujene was notably thinner than for alpha-thujone.
- No constituent-specific numeric dermal reference is available here.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.
- Interaction candidates lack an attached source citation and remain unqualified.